- Home
- JAZZ vs MNSO Comparison
JAZZ vs MNSO Comparison
Compare JAZZ & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- MNSO
- Stock Information
- Founded
- JAZZ 2003
- MNSO 2013
- Country
- JAZZ Ireland
- MNSO China
- Employees
- JAZZ N/A
- MNSO N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- MNSO Department/Specialty Retail Stores
- Sector
- JAZZ Health Care
- MNSO Consumer Discretionary
- Exchange
- JAZZ Nasdaq
- MNSO Nasdaq
- Market Cap
- JAZZ 8.2B
- MNSO 6.8B
- IPO Year
- JAZZ 2007
- MNSO 2020
- Fundamental
- Price
- JAZZ $138.38
- MNSO $22.01
- Analyst Decision
- JAZZ Strong Buy
- MNSO Strong Buy
- Analyst Count
- JAZZ 14
- MNSO 2
- Target Price
- JAZZ $180.14
- MNSO $24.10
- AVG Volume (30 Days)
- JAZZ 670.8K
- MNSO 1.1M
- Earning Date
- JAZZ 11-05-2025
- MNSO 11-28-2025
- Dividend Yield
- JAZZ N/A
- MNSO 2.98%
- EPS Growth
- JAZZ N/A
- MNSO N/A
- EPS
- JAZZ N/A
- MNSO 1.06
- Revenue
- JAZZ $4,086,695,000.00
- MNSO $2,600,350,931.00
- Revenue This Year
- JAZZ $5.70
- MNSO $27.27
- Revenue Next Year
- JAZZ $6.16
- MNSO $18.93
- P/E Ratio
- JAZZ N/A
- MNSO $20.70
- Revenue Growth
- JAZZ 4.52
- MNSO 21.03
- 52 Week Low
- JAZZ $95.49
- MNSO $13.95
- 52 Week High
- JAZZ $148.06
- MNSO $27.71
- Technical
- Relative Strength Index (RSI)
- JAZZ 62.24
- MNSO 47.16
- Support Level
- JAZZ $134.09
- MNSO $21.71
- Resistance Level
- JAZZ $139.75
- MNSO $22.25
- Average True Range (ATR)
- JAZZ 3.08
- MNSO 0.62
- MACD
- JAZZ -0.22
- MNSO -0.01
- Stochastic Oscillator
- JAZZ 81.33
- MNSO 45.77
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About MNSO MINISO Group Holding Limited
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.